Amphastar Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
  • Amphastar Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $6.82M, a 9.02% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2023 was $25.2M, a 5.84% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2022 was $23.8M, a 7.29% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2021 was $22.2M, a 8.32% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.82M +$564K +9.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $6.25M +$637K +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $5.62M -$71K -1.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $5.69M +$970K +20.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $4.72M +$558K +13.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $4.16M +$1.1M +35.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $3.06M -$40K -1.29% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $3.1M +$153K +5.19% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $2.95M +$176K +6.35% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $2.77M -$169K -5.75% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $2.94M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.